European Commission to probe Bayer-Monsanto merger

Bayer AG’s proposed $66 billion acquisition of Monsanto Co has hit a roadblock following a decision by the European Commission to investigate whether the new group could reduce competition for pesticides, seeds and genetically-engineered plant traits.

Full text available to subscribers only. Click here for information on subscribing to MedNous.